Bone Biologics Corp Stock Price on December 2, 2024
| BBLG Stock | USD 1.24 0.03 2.36% |
Below is the normalized historical share price chart for Bone Biologics Corp extending back to March 31, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bone Biologics stands at 1.24, as last reported on the 11th of December 2024, with the highest price reaching 1.24 and the lowest price hitting 1.24 during the day.
If you're considering investing in Bone Stock, it is important to understand the factors that can impact its price. Bone Biologics is very risky given 3 months investment horizon. Bone Biologics Corp secures Sharpe Ratio (or Efficiency) of 0.0681, which signifies that the company had a 0.0681% return per unit of risk over the last 3 months. We were able to break down and interpolate twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.35% are justified by taking the suggested risk. Use Bone Biologics Risk Adjusted Performance of 0.0602, mean deviation of 8.95, and Downside Deviation of 9.28 to evaluate company specific risk that cannot be diversified away.
The Bone Biologics' current Total Stockholder Equity is estimated to increase to about 3.1 M, while Common Stock Shares Outstanding is projected to decrease to roughly 250 K. . At this time, Bone Biologics' Price Fair Value is most likely to increase significantly in the upcoming years. Bone Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of March 2016 | 200 Day MA 1.6773 | 50 Day MA 1.5064 | Beta 0.736 |
Bone |
Sharpe Ratio = 0.0681
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | BBLG | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 19.76 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.35 actual daily | 26 74% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Bone Biologics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bone Biologics by adding it to a well-diversified portfolio.
Price Book 0.799 | Book Value 5.44 | Enterprise Value -536.3 K | Enterprise Value Ebitda 0.1345 | Shares Float 1.7 M |
Bone Biologics Main Headline on 2nd of December 2024
Bone Biologics Co. Short Interest Update by thelincolnianonline.com
Bone Biologics Co. was the recipient of a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 58,200 shares, a decline of 19.3 percent from the October 31st total of 72,100 shares. Approximately 10.9 percent of the shares of the stock are
Bone Biologics Valuation on December 2, 2024
It is possible to determine the worth of Bone Biologics on a given historical date. On December 2, 2024 Bone was worth 1.25 at the beginning of the trading date compared to the closed value of 1.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bone Biologics stock. Still, in general, we apply an absolute valuation method to find Bone Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bone Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bone Biologics' related companies.
| Open | High | Low | Close | Volume | |
| 1.27 | 1.30 | 1.10 | 1.22 | 99,011 | |
12/02/2024 | 1.25 | 1.29 | 1.18 | 1.22 | 131,428 |
| 1.23 | 1.25 | 1.19 | 1.21 | 42,381 |
| Backtest Bone Biologics | | | Bone Biologics History | | | Bone Biologics Valuation | Previous | Next |
Bone Biologics Trading Date Momentum on December 2, 2024
| On December 03 2024 Bone Biologics Corp was traded for 1.21 at the closing time. The top price for the day was 1.25 and the lowest listed price was 1.19 . The trading volume for the day was 42.4 K. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.82% . The overall trading delta against the current closing price is 4.10% . |
Bone Biologics Corp Fundamentals Correlations and Trends
By evaluating Bone Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bone Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bone financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bone Biologics Stock history
Bone Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bone is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bone Biologics Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bone Biologics stock prices may prove useful in developing a viable investing in Bone Biologics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 263.1 K | 250 K | |
| Net Loss | -1.9 M | -1.9 M |
Bone Biologics Stock Technical Analysis
Bone Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bone Biologics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Bone Biologics Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bone Biologics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Bone Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bone Biologics shares will generate the highest return on investment. By undertsting and applying Bone Biologics stock market strength indicators, traders can identify Bone Biologics Corp entry and exit signals to maximize returns
Bone Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bone Biologics' price direction in advance. Along with the technical and fundamental analysis of Bone Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bone to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0602 | |||
| Jensen Alpha | 1.25 | |||
| Total Risk Alpha | (1.72) | |||
| Sortino Ratio | 0.1324 | |||
| Treynor Ratio | 1.61 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Bone Stock analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |